The Jackson Laboratory completed its acquisition of the New York Stem Cell Foundation and formally launched the unified nonprofit organization in New York. JAX leaders said the integration pairs JAX’s mouse genetics and model systems with NYSCF’s automated stem‑cell platforms (Global Stem Cell Array) to accelerate translational research. Lon Cardon and former NIH director Francis Collins attended the ribbon‑tying event and emphasized rapid, patient‑focused gene‑therapy translation as an early priority.